Venus Remedies Ltd
Ticker: VENUSREM
Risky
48/100
☆ Add to Watchlist
Investing Reference
Price
461.50
Market Cap
616.89
Debt/Equity
0.0030
ROE %
8.643
PB
1.0997
Promoter %
41.760
Pledge %
0.000
1Y Rev Growth %
10.722
5Y Rev Growth %
12.540
NP Margin %
6.675
NP Margin 5Y Avg %
6.601
Trading Reference
1M Return %
-0.199
6M Return %
48.154
1Y Return %
32.197
% Away 52W High
23.034
% Away 52W Low
70.768
Daily Volume
62936
Investment Verdict
Buy
Score 75/100 · Position size: 40%
Long-term fundamentals are strong. Suitable for investors with a 1–3+ year horizon.
Trading Verdict
Avoid
Score 35/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Venus Remedies Ltd is currently trading near a key support level, with the 50-day EMA indicating a bullish trend. If the stock breaks above the resistance level, there is potential for a significant upside. However, if it falls below the support, downside risks increase.
Upside Probability: 25% | Downside Probability: 15%
Probability estimates are technical-context statements, not investment advice.
More Options
S
Shri Venkatesh Refineries Ltd
The company faces several challenges, including inconsistent growth and profitability metrics, which make it a risky investment at this time.
View details
S
Swiss Military Consumer Goods Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment.
View details
U
Uni-Abex Alloy Products Ltd
The stock presents several risks with inconsistent growth and moderate profitability metrics, suggesting caution for investors.
View details
U
UTI Nifty Next 50 Exchange Traded Fund
The UTI Nifty Next 50 ETF presents a decent investment opportunity with growth potential, but investors should be cautious of valuation and execution risks.
View details
S
Speciality Restaurants Ltd
While Speciality Restaurants Ltd operates in a growing sector, its inconsistent growth and profitability metrics raise concerns. Caution is advised due to competitive pressures and execution risks.
View details
H
Harita Seating Systems Ltd
Harita Seating Systems Ltd shows potential but faces challenges in growth consistency and market positioning.
View details
I
Iris Clothings Ltd
Iris Clothings Ltd presents several risks with inconsistent growth and profitability metrics, alongside governance concerns, making it a risky investment at this time.
View details
D
Delton Cables Ltd
Delton Cables Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics.
View details
Z
Zodiac Energy Ltd
Zodiac Energy Ltd presents a mixed outlook with significant risks, particularly in growth consistency and market sentiment.
View details
R
Radiant Cash Management Services Ltd
Radiant Cash Management Services Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics.
View details
K
Kerala Ayurveda Ltd
Kerala Ayurveda Ltd shows potential in a growing sector, but faces challenges in execution and profitability.
View details
B
Borana Weaves Ltd
Borana Weaves Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
B
Bella Casa Fashion & Retail Ltd
Bella Casa Fashion & Retail Ltd shows potential but faces challenges in growth consistency and market sentiment.
View details
S
Sical Logistics Ltd
Sical Logistics Ltd shows potential in a growing sector but faces challenges in execution and market sentiment.
View details
K
Kiran Vyapar Ltd
Kiran Vyapar Ltd shows some potential but faces significant challenges in growth and profitability metrics. Caution is advised.
View details
G
GVK Power & Infrastructure Ltd
GVK Power & Infrastructure Ltd presents significant risks with inconsistent performance and high debt levels, making it a risky investment.
View details
Business Overview
Venus Remedies Ltd is a leading Indian pharmaceutical company specializing in innovative and high-quality healthcare solutions. Catering to hospitals, clinics, and healthcare providers, it focuses on critical care and specialty products that enhance patient outcomes. With a commitment to research and development, Venus Remedies stands out for its advanced formulations and global reach. The company is dedicated to improving healthcare standards and accessibility, making it a trusted partner in the medical community.
- Established leader in the pharmaceutical sector
- Focus on critical care and specialty products
- Strong commitment to research and development
- Global presence with a focus on quality
- Enhancing patient outcomes through innovation
Investment Thesis
Venus Remedies Ltd stands out as a compelling investment due to its strong promoter credibility, significant growth potential in digital services, and attractive valuation compared to peers. These factors position the company for sustainable growth and long-term value creation.
- Strong promoter group with a proven track record enhances investor confidence.
- Expanding digital services segment presents a robust growth runway.
- Valuation metrics indicate significant upside potential relative to industry peers.
- Focus on innovation and R&D strengthens competitive positioning.
- Solid financial performance and strategic initiatives drive future growth.
Opportunity vs Risk
Opportunities
- Strong growth in pharmaceutical sector
- Expansion into international markets
- Innovative product pipeline
- Strategic partnerships with healthcare firms
Risks ⚠️
- Regulatory challenges in drug approvals
- Intense competition in the industry
- Fluctuating raw material costs
- Dependence on key patents
Peer Perspective
Venus Remedies Ltd trades at a discount to peers like Cipla and Sun Pharma, reflecting concerns over margin stability. A sustained improvement in operational efficiency could trigger a rerating in the stock.
AI FAQs for Retail Users
- Q: What does Venus Remedies Ltd do?A: Venus Remedies Ltd specializes in developing and manufacturing pharmaceutical products, particularly in the field of critical care and anti-infectives.
- Q: Is Venus Remedies Ltd a profitable company?A: Profitability can vary; it's important to review the latest financial reports and trends.
- Q: What are the risks of investing in Venus Remedies Ltd?A: Risks include market competition, regulatory changes, and potential fluctuations in demand for pharmaceutical products.
- Q: How can I buy shares of Venus Remedies Ltd?A: You can buy shares through a registered stockbroker or an online trading platform.
- Q: Where can I find more information about Venus Remedies Ltd?A: You can check their official website, financial news platforms, and stock market analysis sites.
📊 Stock Investment Checklist (100 Points)
Venus Remedies Ltd • Updated: 2025-09-18 01:35:38
-
8BusinessHighThe company operates in the pharmaceutical sector, which is generally future-ready with a clear model focused on niche markets.
-
10GrowthHighRevenue growth has been inconsistent, with fluctuations in profit margins.
-
10ProfitabilityHighROE and ROCE are moderate, with operating cash flow showing some volatility.
-
9ValuationHighValuation metrics are slightly above peers, indicating potential overvaluation.
-
7BalanceHighThe balance sheet shows manageable debt levels but limited liquidity.
-
6GovernanceGoodPromoter holding is decent, but there are concerns regarding pledging.
-
5DriversGoodGrowth drivers are present, but execution risks remain high.
-
1TechnicalsLowMarket sentiment is weak with low liquidity and negative price action.
Final Score & Verdict
Score 48 / 100
• Risky
Venus Remedies Ltd presents a mixed outlook with significant risks overshadowing its potential growth. Investors should exercise caution.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 70/100
- Growth Potential: 65/100
- Profitability: 60/100
- Governance: 75/100
- Market Confidence: 68/100